FEB 28, 2016 8:39 AM PST

First U.S. Uterus Transplant Revives Pregnancy Hopes For Many

WRITTEN BY: Xuan Pham
Womb transplant a success, a US first

Moving swiftly after announcing the start of the clinical trial in November of 2015, the Cleveland Clinic has recently performed the first uterus transplant in the United States. Doctors hope the 9-hour surgery will fulfill the dreams of their 26-year-old patient to carry and give birth to her own child.
 
This first uterine transplant is one of 10 that Cleveland Clinic will perform as part of their clinical trial. The procedure is specifically for healthy women who suffer from uterine factor infertility (UFI), meaning "they were born without a uterus, have lost their uterus, or have a uterus that no longer functions." To remove donor-related complications, only uteri from deceased donors will be transplanted.
 
 
While the transplant marked a critical step, there are still many more hurdles to overcome. It will take another 12 months for the donated uterus to completely heal inside the recipient’s body. After this period, her previously frozen fertilized eggs are thawed and implanted, one at a time, into the donated uterus until she becomes pregnant.
 
If pregnancy occurs, a high-risk obstetrics team will monitor the mother-to-be closely throughout pregnancy up to delivery. In addition to taking immunosuppressant drugs to prevent organ rejection, she will also undergo monthly cervical biopsies to confirm the organ is still intact. The birth of the baby is strategically carried out via a scheduled cesarean section to prevent labor strains to the transplanted uterus.
 
With so many big steps ahead, the team is cautiously optimistic. So far the University of Gothenburg in Sweden has the claim on the only successful births resulting from uterine transplants. Of nine women who underwent the procedure, four gave births to healthy but premature babies, while two transplants failed and necessitated removal.
 
Importantly, the transplanted uterus is not intended to last a lifetime. Rather, the transplanted organ will be removed via a hysterectomy or be allowed to wither away after the patient has delivered one or two children.
 
While revolutionary, some experts question whether this transplant procedure is the best use of resources, given available options for surrogacy and adoption. However, “There are women who won’t adopt or have surrogates, for reasons that are personal, cultural or religious,” said Dr. Andreas G. Tzakis, lead investigator of the trial. Furthermore, the uterine transplant is the only option that would allow a woman with UFI to biologically experience pregnancy, labor, and delivery.
 
"I crave that experience ... I want the morning sickness, the backaches, the feet swelling. I want to feel the baby move. That is something I've wanted for as long as I can remember," said one hopeful trial candidate. 

Source: CNN
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
APR 13, 2021
Clinical & Molecular DX
A Color-Changing "Invisible Tattoo" for Long-Term Health Monitoring
APR 13, 2021
A Color-Changing "Invisible Tattoo" for Long-Term Health Monitoring
German researchers have developed an innovative method for continuously tracking and monitoring biomarkers and drugs cir ...
MAY 03, 2021
Health & Medicine
The Challenges and Advantages of Direct PCR Amplification
MAY 03, 2021
The Challenges and Advantages of Direct PCR Amplification
  Testing for COVID-19 continues to be one of the most important tools in the global fight to slow and reduce the i ...
MAY 20, 2021
Clinical & Molecular DX
Ovarian Cancer Screening More Beneficial for Early Cancer Detection
MAY 20, 2021
Ovarian Cancer Screening More Beneficial for Early Cancer Detection
A UK-based research study has shown that while ovarian cancer screening is beneficial for detecting cancers earlier, it ...
JUN 01, 2021
Genetics & Genomics
Sequencing and Identifying SARS-CoV-2 Variants Efficiently
JUN 01, 2021
Sequencing and Identifying SARS-CoV-2 Variants Efficiently
  Viral surveillance can give researchers vital information about virus origins, transmission routes, affected popu ...
AUG 19, 2021
Clinical & Molecular DX
Biosensor Illuminates Growing Tumors and Healing Wounds
AUG 19, 2021
Biosensor Illuminates Growing Tumors and Healing Wounds
Cancerous tissues can be difficult to spot, particularly at the early stages. The malignant cells are sometimes indistin ...
SEP 09, 2021
Clinical & Molecular DX
A Drug Test for Synthetic Cannabis Use
SEP 09, 2021
A Drug Test for Synthetic Cannabis Use
Designer drugs are synthetic analogs of prohibited substances such as cocaine and LSD made in clandestine laboratories a ...
Loading Comments...